The condition we now know as seasonal affective disorder (SAD) was first recognized in the early 1980s, when some patients were noted to have symptoms of depression only during the winter months. How does seasonal depression differ from other conditions such as major depression or bipolar disorder? Dr. Norman Rosenthal, a former senior researcher in psychiatry and psychobiology at the National Institute of Mental Health and one of the world's foremost experts on SAD, details the clinical profile of this disorder and describes light therapy and other potential treatments with host Dr. Jennifer Shu. Because there are some similarities between SAD and full depression, is it possible that light therapies or other SAD treatments would be effective for patients with year-round symptoms or bipolar disorder?
SAD: Treating Winter's Doldrums
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The condition we now know as seasonal affective disorder (SAD) was first recognized in the early 1980s, when some patients were noted to have symptoms of depression only during the winter months. How does seasonal depression differ from other conditions such as major depression or bipolar disorder? Dr. Norman Rosenthal, a former senior researcher in psychiatry and psychobiology at the National Institute of Mental Health and one of the world's foremost experts on SAD, details the clinical profile of this disorder and describes light therapy and other potential treatments with host Dr. Jennifer Shu. Because there are some similarities between SAD and full depression, is it possible that light therapies or other SAD treatments would be effective for patients with year-round symptoms or bipolar disorder?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Updates From the 7th World Symposium Task Force
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?